about
Breast cancer 1, early onsetFibroblast growth factor 2Toll-like receptor 3CD34 antigenComplement component 3Insulin-like growth factor 2Cytochrome b-245, beta polypeptideCoagulation factor IIIInterleukin 1 alphaInterleukin 1 alphaHeme oxygenase 1Trans-acting transcription factor 1Fibroblast growth factor 1Neurotrophic tyrosine kinase, receptor, type 1Integrin alpha XCytochrome P450, family 1, subfamily b, polypeptide 1Aquaporin 1Heat shock protein 1Hemolytic complementComplement component 3a receptor 1Thromboxane A2 receptorHepatocyte growth factorPaxillinChemokine (C-C motif) ligand 11Chemokine (C-X3-C motif) ligand 1Cathelicidin antimicrobial peptideChemokine (C-X3-C motif) receptor 1Transforming growth factor, beta receptor IIProstaglandin I2 (prostacyclin) synthaseChemokine (C-X-C motif) receptor 3Signal transducer and activator of transcription 3Growth differentiation factor 2Integrin beta 2Integrin beta 1 (fibronectin receptor beta)Protein kinase C, alphaIntegrin beta 3Receptor (calcitonin) activity modifying protein 2Sphingosine kinase 1Activin A receptor, type II-like 1Chemokine (C-C motif) ligand 5
P682
Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cellsANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivoEphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinomaCloning of a novel gene, ANGPTL4 and the functional study in angiogenesisNon-neuronal nicotinic alpha 7 receptor, a new endothelial target for revascularizationThe influence of exogenous tissue factor on the regulators of proliferation and apoptosis in endothelial cellsA phosphodiesterase 3B-based signaling complex integrates exchange protein activated by cAMP 1 and phosphatidylinositol 3-kinase signals in human arterial endothelial cellsThe role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancerUp-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinomaActivation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cellsBiological characterization of angiopoietin-3 and angiopoietin-4Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesisWnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesisDistinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesisProtein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesisIntermedin is a new angiogenic growth factorIdentification of protein kinase D2 as a pivotal regulator of endothelial cell proliferation, migration, and angiogenesisMyeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarctionAn anti-proliferative gene BTG1 regulates angiogenesis in vitroCXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growthAstrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesisThe effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cellsMicroRNA-214 Is Upregulated in Heart Failure Patients and Suppresses XBP1-Mediated Endothelial Cells AngiogenesisHsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2Antidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesismiR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells.MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses.MicroRNA-185 inhibits angiogenesis in human microvascular endothelial cells through targeting stromal interaction molecule 1.Vascular importance of the miR-212/132 cluster.Hydrogen sulfide promotes angiogenesis by downregulating miR-640 via the VEGFR2/mTOR pathway.MiR-492 impairs the angiogenic potential of endothelial cells.Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia.TGFβ Triggers miR-143/145 Transfer From Smooth Muscle Cells to Endothelial Cells, Thereby Modulating Vessel Stabilization.MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation.EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.MicroRNA-939 governs vascular integrity and angiogenesis through targeting γ-catenin in endothelial cells.microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin.
P921
Q14862232-AA52D722-3462-41DB-9881-8645A1A728B2Q14866180-8D09E389-012D-4FED-A7B1-3653C9B95BB0Q14866180-9AEADB3D-F024-44C7-B443-F04344A5E999Q14866248-DD6EF0BC-7842-48AF-A450-3C7E1B6D26FBQ14873788-ADE5DA0A-C684-4784-AD48-21E62368115EQ14874319-0B6F9EAC-D7DA-4C15-9EDB-52BD9E690A6FQ14874351-C42A089A-013D-45EE-AF98-FF501AB1FD40Q14875845-69132CB4-32DF-4D96-B83B-2B1C60006ECCQ14875845-D7E30FA9-5E29-4F29-9728-E7A9CDE0BE0EQ14877239-8FC56A2A-5052-41C3-A491-FC13DE743D53Q14878193-195A4242-9F90-492F-8905-6E74B4136072Q14878201-D53EA3CC-1C1A-4E8C-ACBB-79083F5AE4D7Q14882925-7417C30C-6EAE-45F6-8636-7204493CB495Q14888116-5C9C7A13-6CBE-4435-B4EF-F8E290D9472BQ14889337-514019F0-EE57-4D5C-876E-9AA2945DDE23Q14901156-783284D0-E981-4AE0-9E22-990DACCDB407Q14904990-8DB56614-2442-4986-9174-4DEBD2F21C2DQ14905167-190977EE-2FA3-4CBC-BC91-4894EBD7A82EQ14905246-C0E04B03-91FA-45B2-B2AA-5D7B992EBD05Q14905265-776ED1D8-3ACE-4903-9D3E-C38C07B2BD9FQ14905308-0200B827-4B4D-4B61-BC33-0BC1A730C7F3Q14905335-F323BB09-42D4-4F77-9E09-B282F47EF5BFQ14905576-B65AA2E0-1510-4130-9F50-0D53C9FF11CAQ14906215-17D7EB28-E9E8-4151-A461-5049B9C22FB4Q14906595-22F3F735-B537-4EE8-8514-B7E5B2E78AC4Q14907652-25CA349C-EB5D-4ACB-AE7E-4D5B7D4C29FEQ14907782-8825DB4F-72E2-4C83-8DC4-C5F69831F1D4Q14907893-3F176249-0D36-4DC8-A857-6FEF015B3AF9Q14911551-11329430-29EA-4FE5-9C8E-9970FDD2AABAQ14911588-E9BA86F4-1C09-49D2-9816-89EB45C70594Q14911843-09971FF2-3D7C-41CF-A774-DC64908B1D96Q14911981-9053A2A9-156B-4E90-AF49-ECA144AEB1A3Q14912021-F1A96EB0-2F64-4B3B-A843-96FD7135D1BBQ14912038-46D3C0F3-D625-4FF2-9DE3-E176A59DC209Q14912069-C326B324-A8B2-46A8-8A67-19AFAD49C439Q14912087-C7AD9F7B-35E4-4323-891E-C10420EE769BQ14912658-DBC17DA7-198A-4DFC-8D13-5EC95AF0FD6EQ14913644-20E862B2-9A7E-4ABF-AC83-8BCE68A3E95BQ14913724-0CAC76C7-6FCE-4E73-ACE5-5A0E2182C5FFQ14913839-139902A8-9EB7-4CF3-A8A5-7CFA2FCBE828
P682
Q24291100-21F273F6-8E8B-4560-A3FC-0B051205A9CEQ24292398-0FB1637A-6CAC-4F09-AB26-9FD3A98E3F4EQ24293620-32E74747-0047-46D5-A540-EF605A0159A3Q24294336-0317F570-C7E4-4D1B-9074-5DEC8BDDA470Q24294437-A012B332-0397-4609-82AB-1D2F7BB39AD3Q24295047-78711B46-9B2D-4DC1-9CC9-78B633E38057Q24296340-466274F2-2E03-486A-8360-4C461B053AD6Q24298074-959657DA-52FA-4686-813F-06F2DF5617CAQ24299889-4EC9FCD8-E359-4BA6-A722-EA99241C0A40Q24300331-62AF8992-23C2-4D0B-8968-D250B4D83451Q24300341-4E6CD61F-2BAE-4D23-901D-7E26AAFB34ACQ24301960-98B0C978-3C90-4D04-8AF4-7914F7564A28Q24306687-ED7E5AD3-6316-4610-8468-4628956549CCQ24307624-1AF2C3E3-B931-4F3D-89FC-49990C0397DAQ24309476-D1D3E3F9-1AFC-42F6-8B40-FD203296B930Q24309609-8DD536B2-EED1-46D6-BAF4-836ADD457F5CQ24313298-CBBA4A01-E47D-4EF0-9704-3B4FF5FEABAEQ24313566-D2212580-8336-4FAF-A6A3-E2D209E2BE29Q24314350-C21A19ED-4808-40B2-B8BE-3317F334D2A2Q24318294-09012EF1-5A96-4884-A03F-1ADA4FED22AEQ24318416-D43D9F04-3B4F-4C6F-B9BB-9EB9BFD28230Q24319862-76CECC9F-7FCC-4A18-B795-EBF180EE4FF9Q24321673-833BBC0E-E5B8-4708-AA90-FF727634FC22Q24328998-9498E3AD-109A-4FED-83CA-A7AE54AE57FEQ28115504-44075E4E-B386-431B-873E-C3D4C2ABF5A5Q28118019-8A22A755-9C89-4AD8-B81F-D9AA5F38F6C3Q28119160-0C4F08FB-A7E3-4477-9604-08C7B8A45AA2Q34503190-402BDA9F-4C31-47F0-A782-AD96265DE15DQ38313277-DD72C425-98BC-41E1-89A0-B9831741858FQ38809740-6EE21040-774C-4895-B2B3-88ABED4B7C18Q42428330-2A5B0028-49DF-4788-AAC4-6479A9034450Q42428357-60050DE2-482C-46EC-A8EF-9B8A0E54DBE9Q42971453-5E97E767-7637-4824-B8E6-36E5470718C9Q45061832-61BB22B9-08B5-4FCF-8FD0-18B27AF5ABB6Q46491669-1134E295-F001-49F0-8776-1CD5221C8C22Q47074401-59CCB470-9DEF-4F72-B922-30F6EF212D70Q47771365-8E869ED3-563A-44DD-9CC5-C8A69D112F06Q50320369-3EE91002-AF06-421C-B664-69558A4EF98BQ50320374-6A301DA2-62CA-4590-9952-4EA50CC8BC06
P921
description
Any process that activates or increases angiogenesis.
@en
biologisch proces
@nl
name
positiv regulering av angiogenese
@nn
positive regulation of angiogenesis
@en
type
label
positiv regulering av angiogenese
@nn
positive regulation of angiogenesis
@en
altLabel
GO:0045766
@en
GO:0045766
@nn
up regulation of angiogenesis
@en
up-regulation of angiogenesis
@en
upregulation of angiogenesis
@en
prefLabel
positiv regulering av angiogenese
@nn
positive regulation of angiogenesis
@en
P128
P2888
P686
GO:0045766